Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
105.28
-0.12 (-0.11%)
At close: Aug 8, 2025, 4:00 PM
105.50
+0.22 (0.21%)
After-hours: Aug 8, 2025, 5:50 PM EDT
Verona Pharma Revenue
Verona Pharma had revenue of $103.14M in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $221.67M. In the year 2024, Verona Pharma had annual revenue of $42.28M.
Revenue (ttm)
$221.67M
Revenue Growth
n/a
P/S Ratio
39.77
Revenue / Employee
$1,060,636
Employees
209
Market Cap
9.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.28M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 458.00K | -39.54M | -98.86% |
| Dec 31, 2021 | 40.00M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Novo Nordisk | 49.11B |
| Eli Lilly and Company | 49.00B |
VRNA News
- 27 days ago - VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA - Business Wire
- 4 weeks ago - Major deals involving U.S. drugmakers and biotechs over the past decade - Reuters
- 4 weeks ago - Two big reasons why buying Verona was crucial for Merck - Invezz
- 4 weeks ago - Merck has struck a roughly $10 billion deal to buy Verona Pharma - WSJ
- 4 weeks ago - Verona Pharma shares jump with Merck set to acquire company in $10 billion deal - Invezz
- 4 weeks ago - Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - Market Watch
- 4 weeks ago - Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck. - Barrons
- 4 weeks ago - Merck to Buy Verona Pharma in $10 Billion Deal - WSJ